Fed decision, oil plunge, mixed earnings — what we're watching into the stock market close

All You Need to Know About Bausch (BHC) Rating Upgrade to Buy

All You Need to Know About Bausch (BHC) Rating Upgrade to Buy

12 portfolio companies report earnings in the week ahead. What we want to hear from each

Here’s a rapid-fire update on all 33 portfolio stocks including our tech giants reporting this week

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says

Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC) and Enlivex (ENLV)

Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Walgreens Boots Alliance (WBA) and Evolent Health (EVH)

Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Arcus Biosciences (RCUS)

Bausch Health to Announce First-Quarter 2024 Results on May 2

Morgan Stanley tumbles, GE Healthcare climbs — what's driving Thursday's major portfolio stock moves

Bausch Health Wins Patent Appeal for XIFAXAN

Bausch wins US appeal to block Alvogen generic of diarrhea drug

Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029

Bausch wins US appeal to block Alvogen generic of diarrhea drug

Will Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?

Will Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?

Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan

CANADA STOCKS-TSX ends flat as gold stocks drop, mood cautious ahead of rate decision